WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Wednesday reported a loss of $94.4 million in its first quarter.

The West Conshohocken, Pennsylvania-based company said it had a loss of $3.25 per share.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $3.61 per share.

The biopharmaceutical company posted revenue of $311.3 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $301.2 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDGL at https://www.zacks.com/ap/MDGL